Phase IV Study of FDA Approved, Once-Daily GRALISE™(Gabapentin) Tablets for the Treatment of Postherpetic Neuralgia
NCT01426230 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 201
Last updated 2013-03-21
Summary
Study objective is to assess the safety and effectiveness of once- daily GRALISE in clinical practice
Conditions
- Post Herpetic Neuralgia
Sponsors & Collaborators
-
Depomed
lead INDUSTRY
Principal Investigators
-
Rekha Sathyanarayana · Depomed Clinical Operations
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-09-30
- Primary Completion
- 2012-03-31
- Completion
- 2012-04-30
Countries
- United States
Study Locations
More Related Trials
-
A Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN)
NCT00619476 ·Status: COMPLETED ·Phase: PHASE2
-
Once Daily Gabapentin in the Treatment of Post Amputation Pain
NCT01776671 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety/Efficacy Study of Retigabine vs. Placebo in Post-Herpetic Neuralgia (PHN)
NCT00612105 ·Status: COMPLETED ·Phase: PHASE2
-
Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia
NCT01270828 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Postherpetic Neuralgia.
NCT00150436 ·Status: COMPLETED ·Phase: PHASE3
-
Reduction of Postherpetic Neuralgia in Herpes Zoster
NCT01250561 ·Status: COMPLETED ·Phase: NA
-
Pregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN)
NCT01455428 ·Status: COMPLETED ·Phase: PHASE4
-
Dose-Response and Pharmacokinetics of Gabapentin Enacarbil (GEn [XP13512 / GSK1838262]) in Restless Legs Syndrome
NCT01332305 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Safety and Efficacy of 7 Days Treatment With a Novel Analgesic in Subjects With Peripheral Neuropathic Pain
NCT01485094 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of Pregabalin for the Treatment of Diabetic Peripheral Neuropathy or Postherpetic Neuralgia
NCT00629681 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Pregabalin Sustained Release Tablet for Postherpetic Neuralgia
NCT02868801 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of Gabapentin/B-complex Versus Pregabalin in Diabetic Peripheral Neuropathy Pain Management
NCT01364298 ·Status: COMPLETED ·Phase: PHASE4
-
Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome.
NCT00311363 ·Status: COMPLETED ·Phase: PHASE3
-
XP13512 (Gabapentin Enacarbil) Extension Study in Patients With Restless Legs Syndrome.
NCT00333359 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Pregabalin Therapy for Pain Relief in Subjects With Post-Herpetic Neuralgia
NCT00159666 ·Status: COMPLETED ·Phase: PHASE4
-
Drug Use Investigation Of Gabapentin
NCT00567268 ·Status: COMPLETED
-
Pilot Study Of Pregabalin And Prediction Of Treatment Response In Patients With Postherpetic Neuralgia
NCT01603394 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Chronic Neuropathic Pain.
NCT00141362 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures
NCT00537940 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia
NCT01678924 ·Status: TERMINATED ·Phase: PHASE2
-
Comparison of Gabapentin and Pregabalin for Radicular Pain
NCT02064790 ·Status: COMPLETED
-
Simulated Driving Performance, Daytime Sedation and Cognition in Healthy Volunteers Taking Gralise, Neurontin or Lyrica
NCT03179345 ·Status: COMPLETED ·Phase: PHASE4
-
A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia
NCT00424372 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Of The Efficacy Of Gabapentin In Neuropathic Pain Patients As Measured By Quantitative Sensory Testing
NCT00674687 ·Status: COMPLETED ·Phase: NA
-
Pregabalin Treatment and Prevention Post-herpetic Neuralgia
NCT03186443 ·Status: UNKNOWN ·Phase: PHASE3